NASDAQ: MYGN
Myriad Genetics Inc Earnings Dates, Reports, Calls

Myriad Genetics earnings were -$116.0M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest MYGN earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$22.1M, down 39.8% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, MYGN reported annual earnings of -$263.3M, with 135.1% growth. The next MYGN earnings date is Feb 25, 2025.

MYGN earnings history

Current Revenue
$823.6M
Current Earnings
-$116.0M
Current Profit Margin
-14.1%

MYGN Return on Equity

Current Company
-15.4%
Current Industry
-13.8%
Current Market
35%
MYGN's Return on Equity (-15.4%)... subscribe to Premium to read more.
High Return on Equity Performance

MYGN Return on Assets

Current Company
-10.5%
Current Industry
5.9%
MYGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MYGN announces earnings.

MYGN Return on Capital Employed

Current Company
-12.25%
Current Industry
10.5%
MYGN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MYGN vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MYGN-$42.70M-$116.00MN/A-$1.28
CDNA-$135.01M-$143.56MN/A-$2.69
OPK$18.94M-$133.73MN/A-$0.18
LAB-$104.99M-$170.60MN/A-$0.71
NEO$21.02M-$77.73MN/A-$0.61

MYGN earnings dates

Next earnings date
Feb 25, 2025

Myriad Genetics Earnings Reports & History FAQ

What were Myriad Genetics's earnings last quarter?

On MYGN's earnings call on Invalid Date, Myriad Genetics (NASDAQ: MYGN) reported Q3 2024 earnings per share (EPS) of -$0.24, up 68% year over year. Total MYGN earnings for the quarter were -$22.10 million. In the same quarter last year, Myriad Genetics's earnings per share (EPS) was -$0.75.

If you're new to stock investing, here's how to buy Myriad Genetics stock.

When does Myriad Genetics report earnings?

The next MYGN earnings call is Invalid Date. Add MYGN to your watchlist to be reminded of Myriad Genetics's next earnings date.

What was MYGN's earnings growth in the past year?

As of Myriad Genetics's earnings date in Invalid Date, Myriad Genetics's earnings has grown year over year. MYGN earnings in the past year totalled -$116.00 million.

Is Myriad Genetics profitable or losing money?

As of the last Myriad Genetics earnings report, Myriad Genetics is currently losing money. Myriad Genetics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$116.00 million, a 57.73% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.